BCRX - Biocryst Pharmaceuticals Inc Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: AMPH ANIP PTCT SUPN HROW

| Held by: VTI XBI IWM VB VXF VBK IBB IWO CALF VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	15.66%	Shs Outstand	254.01M	Perf Week	-8.09%
Market Cap	2.11B	Forward P/E	26.46	EPS next Y	0.31	Insider Trans	-1.19%	Shs Float	214.36M	Perf Month	-5.37%
Enterprise Value	2.73B	PEG	-	EPS next Q	0.16	Inst Own	84.53%	Short Float	17.46%	Perf Quarter	9.37%
Income	-457.98M	P/S	2.38	EPS this Y	-321.28%	Inst Trans	16.99%	Short Ratio	6.79	Perf Half Y	19.62%
Sales	885.72M	P/B	-	EPS next Y	111.70%	ROA	-96.92%	Short Interest	37.42M	Perf YTD	6.28%
Book/sh	-2.18	P/C	8.81	EPS next 5Y	-29.26%	ROE	-	52W High	11.31 -26.70%	Perf Year	-20.21%
Cash/sh	0.94	P/FCF	7.19	EPS past 3/5Y	- -	ROIC	-175.59%	52W Low	6.00 38.17%	Perf 3Y	-3.27%
Dividend Est.	-	EV/EBITDA	8.57	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.52%	Volatility	3.53% 4.88%	Perf 5Y	-40.19%
Dividend TTM	-	EV/Sales	3.08	EPS Y/Y TTM	-569.22%	Oper. Margin	35.67%	ATR (14)	0.42	Perf 10Y	149.70%
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	75.92%	Profit Margin	-51.71%	RSI (14)	38.04	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	-2979600.00%	SMA20	-7.06%	Beta	0.56	Target Price	21.30
Payout	0.00%	Debt/Eq	-	Sales Q/Q	7.48%	SMA50	-9.74%	Rel Volume	0.75	Prev Close	8.37
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	4.78%	Avg Volume	5.51M	Price	8.29
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6826.86% 3.50%	Trades		Volume	4,148,800	Change	-0.96%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)